MedTrace Logo

Intrarenal Microvasculature in ADPKD

NCT05288998 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 34

Last updated 2026-01-16

No results posted yet for this study

Summary

The primary objective of this study is to evaluate the use of Super-resolution ultrasound (SRU) to assess the intrarenal microvasculature in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) and healthy volunteers.

Conditions

  • Autosomal Dominant Polycystic Kidney Disease

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Maria V Irazabal, M.D., Ph.D · Mayo Clinic

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-30
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05288998 on ClinicalTrials.gov